Health Sciences Clinical Professor (Recalled), Internal Medicine, UCSF School of Medicine
Internal Medicine
Dr. Curt A. Ries, MD
|
|
Give Review
Dr. Curt A. Ries works in the field of Internal Medicine. He went to University of Rochester School of Medicine and Dentistry. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Curt A. Ries, MD has written publications. He has 25 publications published with PubMed. The lastest paper is: 'Lung transplantation for pulmonary amyloidosis: a case report.' He is registered with Medicare and accepts Medicare payments.
Publications
- Lung transplantation for pulmonary amyloidosis: a case report.
- Treatment of refractory chronic lymphocytic Leukemia with prednimustine: a phase II study using strict response criteria.
- A phase II study of prednimustine in Acute non-lymphocytic leukemia, smouldering leukemia, and refractory anemia with excess blasts.
- The role of endoscopic evaluation in patients with suspected intestinal graft-versus-host Disease after allogeneic bone-marrow transplantation.
- High-dose chemotherapy for peripheral stem cell procurement in Leukemia, lymphoma and multiple myeloma.
- Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic.
- Fungal infections in patients with Acute leukemia.
- Computerized tomography in the diagnosis of systemic candidiasis in patients with Acute leukemia.
- Improved results of treatment of adult Acute lymphoblastic leukemia.
- Teniposide (VM-26) and ara-C in the treatment of adult Acute lymphoblastic leukemia.
- Autologous stem cell transplantation for Acute myeloid leukemia in first remission.
- High-dose chemotherapy (CTM) for breast cancer.
- Delayed engraftment of 4-hydroperoxycyclophosphamide-purged autologous bone marrow after induction treatment containing mitoxantrone for Acute myelogenous leukemia.
- Treatment of adult Acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report.
- Cytoreduction of lymphoid malignancies and mobilization of blood hematopoietic progenitor cells with high doses of cyclophosphamide and etoposide plus filgrastim.
- High CD34+ cell dose promotes faster platelet recovery after autologous stem cell transplantation for Acute myeloid leukemia.
- Autologous bone marrow transplantation for Acute myeloid leukemia using 4-hydroperoxycyclophosphamide-purged bone marrow and the busulfan/etoposide preparative regimen...
- High-dose cytarabine dose modification reduces the incidence of neurotoxicity in patients with renal insufficiency.
- Post-remission cytopenias following intense induction chemotherapy for Acute myeloid leukemia.
- Autologous stem cell transplantation for advanced Acute myeloid leukemia.
- Intensified and shortened cyclical chemotherapy for adult Acute lymphoblastic leukemia.
- Autologous bone marrow transplantation for Acute myeloid leukemia using busulfan plus etoposide as a preparative regimen.
- Busulfan plus etoposide as a preparative regimen for autologous bone marrow transplantation for Acute myelogenous leukemia: an update.
- Treatment of Acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule.
Schools
University Of Rochester
Strong Meml Hospital University Rochester
University Calif
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Chronic Myeloid Leukemia (CML)
- View All
Doctors Specialties
- Hematology
- Internal Medicine
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
UCSF -
University of Rochester -
University of Rochester School of Medicine and Dentistry
Hospital
-
San Francisco General Hospital and Trauma Center -
UCSF Medical Center
Drug Facts
| NPI NUMBER | 1922065994 | |
| NPPES Provider LastName | RIES | |
| NPPES Provider FirstName | CURT | |
| NPPES Provider ZIPCode | 941432202 | |
| NPPES Provider State | CA | |
| Specialty Description | Hematology | |
| Total Claim Count | 81.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1922065994 |
| Last Name Of The Provider | RIES |
| First Name Of The Provider | CURT |
| View All |
Similar Doctors
|
|
Dr. Andrew B. Bindman, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jeffrey N. Siegel, MD |
|
|
Dr. Xiao Yang, MD |
|
|
Dr. Samira Y. Ahmed, MD |
|
|
Dr. Kristoff A. Olson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Blake T. Henderson, MD |
|
|
Dr. Nancy K. Valente, MD |